Land: Australien
Sprache: Englisch
Quelle: Department of Health (Therapeutic Goods Administration)
bromhexine hydrochloride
Sanofi-Aventis Healthcare Pty Ltd T/A Sanofi Consumer Healthcare
Bromhexine hydrochloride
Registered
bischesty- ccds 0052-09-piv8-25oct19 Page 1 of 11 AUSTRALIAN PRODUCT INFORMATION – BISOLVON ® CHESTY (BROMHEXINE HYDROCHLORIDE) 1 NAME OF THE MEDICINE Bromhexine hydrochloride 2 QUALITATIVE AND QUANTITATIVE COMPOSITION BISOLVON CHESTY ORAL LIQUID contains 4 mg/5mL of bromhexine hydrochloride BISOLVON CHESTY KIDS ORAL LIQUID contains 4 mg/5mL of bromhexine hydrochloride BISOLVON CHESTY FORTE ORAL LIQUID contains 8 mg/5mL of bromhexine hydrochloride BISOLVON CHESTY FORTE TABLETS contains 8 mg per tablet of bromhexine hydrochloride BISOLVON CHESTY FORTE LIQUID ON-THE-GO SACHETS contains 4 mg/5mL of bromhexine hydrochloride BISOLVON CHESTY FORTE SOLUBLE TABLETS contains 4 mg/5mL of bromhexine hydrochloride Excipients with known effect: sugars, sucralose, maltitol and benzoates. For the full list of excipients, see Section 6.1 LIST OF EXCIPIENTS. 3 PHARMACEUTICAL FORM BISOLVON CHESTY ORAL LIQUID is a clear to almost clear and colourless to almost colourless solution with an aroma of chocolate and cherry. BISOLVON CHESTY KIDS ORAL LIQUID is a clear to almost clear and colourless to almost colourless solution with a fruity aromatic odour of strawberry. BISOLVON CHESTY FORTE ORAL LIQUID is a clear to almost clear and colourless to almost colourless solution with an aroma of chocolate and cherry. BISOLVON CHESTY FORTE TABLETS are round, white and bevel-edged tablets. One side is scored and impressed with ‘51B’ on both sides of the score. BISOLVON CHESTY FORTE LIQUID ON-THE-GO SACHETs is a clear to almost clear and colourless to almost colourless solution with an aroma of chocolate and cherry BISOLVON CHESTY FORTE SOLUBLE TABLETS the tablets are square, cushion-shaped, shallowly convex, beige-yellow tablets with rounded edges and orange dots. bischesty- ccds 0052-09-piv8-25oct19 Page 2 of 11 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS For use as a mucolytic to break down mucus and help clear the chest in conditions accompanied by excessive mucus secretions, such as in the common cold, influenza, infections of Lesen Sie das vollständige Dokument